openPR Logo
Press release

Clinical Oncology Next Generation Sequencing Market Expansion in North America Europe and Asia Pacific

12-18-2025 07:54 AM CET | Health & Medicine

Press release from: Insightace Analytic Pvt Ltd.

Clinical Oncology Next Generation Sequencing Market

Clinical Oncology Next Generation Sequencing Market

"Clinical Oncology Next Generation Sequencing Market" in terms of revenue was estimated to be worth USD 474.2 Mn in 2024 and is poised to reach USD 2,069.7 Mn by the year 2034, growing at a CAGR of 16.0% from 2025 to 2034 according to a new report by InsightAce Analytic.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2249

Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors shaping the global Clinical Oncology Next Generation Sequencing Market include:
• Growing demand for personalized medicine and targeted therapies
• Technological advancements in next-generation sequencing (NGS) techniques
• Increasing prevalence of cancer cases worldwide

Primary obstacles to the Clinical Oncology Next Generation Sequencing Market's expansion consist of:
• High costs associated with NGS technology and data analysis
• Lack of standardization and regulatory challenges in data interpretation
• Limited reimbursement policies for NGS-based tests

Future expansion opportunities for the global Clinical Oncology Next Generation Sequencing Market involve:
• Integration of artificial intelligence and machine learning in NGS data analysis for enhanced precision and efficiency
• Expansion of NGS applications beyond cancer diagnosis to encompass treatment response monitoring and minimal residual disease detection
• Collaborations between pharmaceutical companies and NGS service providers to develop companion diagnostics for targeted therapies

Market Analysis:
Key factors driving the growth of the Clinical Oncology Next Generation Sequencing (NGS) market include continuous technological advancements, heightened competitive activity among industry players, increasing healthcare expenditure, and the rising global prevalence of cancer. Ongoing research and development efforts aimed at improving diagnostic and therapeutic solutions are anticipated to further reinforce market expansion. The market was also notably influenced by the COVID-19 pandemic, as government regulations and updated clinical guidelines for cancer management affected the demand for NGS-based oncology solutions.

List of Prominent Players in the Clinical Oncology Next Generation Sequencing Market:
• Illumina, Inc. (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Agilent Technologies Inc. (U.S.)
• Myriad Genetics Inc. (U.S.)
• BGI (China)
• Perkin Elmer Inc. (U.S.)
• Foundation Medicine Inc. (U.S.)
• PacBio (U.S.)
• Oxford Nanopore Technologies plc. (U.K.)
• Paradigm Diagnostics Inc. (U.S.)
• Caris Life Sciences (Japan)
• Partek, Incorporated (U.S.)
• Eurofins Scientific (Luxembourg)
• Qiagen (Germany)

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Recent Developments:
• In January 2022, Agendia, Inc. unveiled a multiyear collaboration with Illumina to jointly create in vitro diagnostic (IVD) assays for oncology testing.
• In October 2021, Roche launched the AVENIO tumor tissue CGP kit to enhance accessibility to personalized cancer research.

Clinical Oncology Next Generation Sequencing (NGS) Market Dynamics
Market Drivers:
The growth of the Clinical Oncology Next Generation Sequencing (NGS) market is being driven by the rising incidence of cancer and advancements in personalized medicine and oncology-targeted therapeutics. Key factors contributing to market expansion include the increasing adoption of sequencing-based diagnostic tools among oncologists, declining costs of genetic sequencing technologies, and expanded government funding for research and development initiatives.

Market Challenges:
Despite promising growth prospects, high implementation costs remain a significant barrier to market development. The substantial capital investment required to acquire and operate advanced sequencing platforms, inefficiencies associated with outsourcing sequencing services, and limited accessibility of these technologies in certain regions are expected to constrain market expansion during the forecast period.

Regional Insights - North America:
North America is anticipated to exhibit the highest compound annual growth rate (CAGR) in the Clinical Oncology NGS market over the forecast period. This growth is supported by strong regulatory initiatives aimed at enhancing cancer diagnostics in the United States, increased investment in research and development, and the presence of leading industry players. Market participants are increasingly prioritizing technological innovation to strengthen their competitive positioning and deliver more advanced diagnostic solutions.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2249

Segmentation of Clinical Oncology Next Generation Sequencing Market-
By Technology
• Whole Genome Sequencing
• Whole Exome Sequencing
• Targeted Sequencing and Resequencing Centrifuges
By Workflow
• Pre-Sequencing
• Sequencing
• Data Analysis
By Application
• Screening
• Sporadic Cancer
• Inherited Cancer
• Companion Diagnostics
• Other Diagnostics
By End-user
• Hospitals
• Clinics
• Laboratories
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/clinical-oncology-next-generation-sequencing-market-/2249

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Oncology Next Generation Sequencing Market Expansion in North America Europe and Asia Pacific here

News-ID: 4320102 • Views:

More Releases from Insightace Analytic Pvt Ltd.

Gene Therapy Market Outlook Indicates Rapid Adoption Across Oncology Neurology and Hepatology
Gene Therapy Market Outlook Indicates Rapid Adoption Across Oncology Neurology a …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Gene Therapy Market- (By Type (Gene silencing, Cell replacement, Gene augmentation, Other therapies), By Vector (Viral vectors (Retroviral Vectors (Gamma Retroviral Vectors, Lentiviral Vectors), Adeno-Associated Viral Vectors, Other Viral Vectors), Non-Viral Vectors (Oligonucleotides, Other Non-Viral Vectors)), By Therapeutic area (Neurology, Oncology, Hepatology, Other therapeutic areas), By Delivery method (In Vivo, Ex Vivo), By Route Of
Emerging Technology in Fintech Market Trends Highlight Wealth Management and Insurance Applications
Emerging Technology in Fintech Market Trends Highlight Wealth Management and Ins …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Emerging Technology in Fintech Market Size, Share & Trends Analysis Report Technology (Artificial Intelligence, Blockchain, Cloud & Edge Computing, Quantum Computing), Application (Lending, Payments, Wealth Management, Insurance)-Market Outlook And Industry Analysis 2034" Global Emerging Technology in Fintech Market Size is valued at US$ 289.8 Bn in 2024 and is predicted to reach US$ 2,369.8 Bn
Electric Powertrain Market Development Driven by Axial Flux Motors PMSM and Dual Motor Systems
Electric Powertrain Market Development Driven by Axial Flux Motors PMSM and Dual …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Electric Powertrain Market"-, By Integration Type (Integrated & Non-integrated), Component (Motor, Battery, BMS, Controller, PDM, Inverter/Converter, On-Board Charger), Propulsion (BEV, PHEV), Vehicle Type (PC & LCV), and Global Forecasts, 2024-2031 And Segment Revenue and Forecast To 2031." The Electric Powertrain Market is estimated to reach over USD 301.6 billion by 2031, exhibiting a CAGR of 17.1%
Edge Data Center Market Adoption Rising with Manufacturing Automotive and Retail Applications
Edge Data Center Market Adoption Rising with Manufacturing Automotive and Retail …
InsightAce Analytic Pvt. Ltd. Announces the release of a market assessment report on the "Edge Data Center Market"-, By End-Use Industry (IT and Telecom, Banking, Financial Services, Insurance (BFSI), Government and Public Sector, Healthcare, Manufacturing, Automotive, Retail, Others), By Data Center Type (On-Premise Edge, Network Edge, Regional Edge), and Global Forecasts, 2024-2031 And Segment Revenue and Forecast To 2031." The Edge Data Center Market is estimated to reach over USD

All 5 Releases


More Releases for Sequencing

Sequencing Reagents Market Report 2024 - Sequencing Reagents Market Trends And S …
"The Business Research Company recently released a comprehensive report on the Global Sequencing Reagents Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample
Sequencing the Future: Next Generation Sequencing Market Projections (2023-2033)
The global Next-generation Sequencing Market was over 8.5 billion in 2022 and it is anticipated to grow at a CAGR of over 18.2% during the forecast period. Market Outlook: The Next Generation Sequencing (NGS) market is set for an extraordinary trajectory of growth and innovation from 2023 to 2033. This decade is poised to witness a paradigm shift in genomics and molecular biology, with NGS technologies playing a central role in reshaping
Sequencing Reagents Market - Elevating Accuracy, Inspiring Discovery: Revolution …
Newark, New Castle, USA - new report, titled Sequencing Reagents Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Sequencing Reagents market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Sequencing Reagents market. The report offers an overview of the market, which
Microbiome Sequencing Services Market By Technology (Sequencing By Synthesis (SB …
Microbiome are the group of microorganisms that grow on saliva, skin layers, conjunctiva, oral mucosa and the gastrointestinal tract. Microbiome sequencing is the study and analysis of microbes groups located outside and inside of the human body to gain knowledge about human microbes. Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00004419/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis: Baseclear B.V. Clinical-Microbiomics A/S Molzym GmbH & Co. Kg Zymo Research Corp. Rancho Biosciences Microbiome Therapeutics, LLC. Microbiome Insights Inc. Openbiome Resphera Biosciences, LLC. Ubiome, Inc. The report covers key developments
Next Generation Sequencing Market Growth of Technological Advancements in Sequen …
Research Report on Next Generation Sequencing Market providing Global Industry Scenario for 5 years (2019 to 2026) is now available under the Life Sciences Section of Search4Research.com Get Research Sample PDF at https://www.search4research.com/request-sample/113582/ Global Next Generation Sequencing Market Trends, Competitive Analysis and Forecast Report 2018-2026 is an exhaustive study on the present market scenario of the global Next Generation Sequencing industry with a special focus on the United States, Europe,
Metagenomic Sequencing Market Technology Outlook 2027 - 16s Rrna Sequencing, Sho …
Worldwide Metagenomic Sequencing Market Analysis to 2027 is a specialized and in-depth study of the Metagenomic Sequencing Industry with a focus on the global market trend. The report aims to provide an overview of global Metagenomic Sequencing Market with detailed market segmentation by product/application and geography. The global Metagenomic Sequencing Market is expected to witness high growth during the forecast period. Metagenomics, is a field where genomic analysis of microbial DNA